Depressive symptoms, antidepressant use, and the incidence of diabetes in the Black Women's Health Study

Diabetes Care

Volumn 37, Issue 8, 2014, Pages 2211-2217

  Vimalananda, Varsha G ^a   Palmer, Julie R ^b,c   Gerlovin, Hanna ^b,c   Wise, Lauren A ^b,c   Rosenzweig, James L ^a   Rosenberg, Lynn ^b,c   Ruiz Narváez, Edward A ^b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; COHORT ANALYSIS; DEPRESSION; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; LIFESTYLE; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; WOMEN'S HEALTH; ATTITUDE TO HEALTH; COMORBIDITY; DIABETES MELLITUS, TYPE 2; EPIDEMIOLOGY; ETHNOLOGY; FOLLOW UP; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AFRICAN AMERICANS; ANTIDEPRESSIVE AGENTS; ATTITUDE TO HEALTH; COHORT STUDIES; COMORBIDITY; DEPRESSION; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIFE STYLE; MIDDLE AGED; OBESITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES; WOMEN'S HEALTH;

EID: 84905001387     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-2642     Document Type: Article

References (44)

1. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006; 29: 1263-1268
2. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001; 414: 782-787
3. Flegal KM, Carroll MD, Kit B.K., Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497
4. Crespo CJ, Keteyian SJ, Heath G.W., Sempos CT. Leisure-time physical activity among US adults. Results from the Third National Health and Nutrition Examination Survey. Arch Intern Med 1996; 156: 93-98
5. Palinkas LA, Lee PP, Barrett-Connor E. A prospective study of type 2diabetesand depressive symptoms in the elderly: the Rancho Bernardo Study. Diabet Med 2004; 21: 1185-1191
6. Arroyo C, Hu FB, Ryan L.M., et al. Depressive symptoms and risk of type 2 diabetes in women. Diabetes Care 2004; 27: 129-133
7. Carnethon MR, Biggs ML, Barzilay J.I., et al. Longitudinal association between depressive symptoms and incident type 2 diabetes mellitus in older adults: the cardiovascular health study. Arch Intern Med 2007; 167: 802-807
8. Mezuk B, Eaton WW, Albrecht S, Golden SH Depression and type 2 diabetes over the lifespan: a meta-analysis. Diabetes Care 2008; 31: 2383-2390
9. Eaton WW, Armenian H, Gallo J., Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care 1996; 19: 1097-1102
10. Golden SH, Lee HB, Schreiner P.J., et al. Depression and type 2 diabetes mellitus: the multiethnic study of atherosclerosis. Psychosom Med 2007; 69: 529-536
11. Golden SH, Williams JE, Ford D.E., et al.; Atherosclerosis Risk in Communities study. Depressive symptoms and the risk of type 2 diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2004; 27: 429-435
12. Pan A, Lucas M, Sun Q., et al. Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med 2010; 170: 1884-1891
13. Ma Y, Balasubramanian R, Pagoto S.L., et al. Elevated depressive symptoms, antidepressant use, and diabetes in a large multiethnic national sample of postmenopausal women. Diabetes Care 2011; 34: 2390-2392
14. Schmidt MI, Duncan BB, Sharrett A.R., et al. Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 1999; 353: 1649-1652
15. Golden SH. A review of the evidence for a neuroendocrine link betweenstress, depression and diabetes mellitus. Curr Diabetes Rev 2007; 3: 252-259
16. Everson-Rose S.A., Meyer PM, Powell L.H., et al. Depressive symptoms, insulin resistance, and risk of diabetes in women at midlife. Diabetes Care 2004; 27: 2856-2862
17. Everson-Rose S.A., House JS, Mero RP Depressive symptoms and mortality risk in a national sample: confounding effects of health status. Psychosom Med 2004; 66: 823-830
18. Knol MJ, Twisk JW, Beekman A.T., Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006; 49: 837-845
19. Ma Y, Hébert JR, Manson J.E., et al. Determinants of racial/ethnic disparities in incidence of diabetes in postmenopausal women in the U.S.: The Women's Health Initiative 1993-2009. Diabetes Care 2012; 35: 2226-2234
20. Pan A, Sun Q, Okereke O.I., et al. Use of antidepressant medication and risk of type 2 diabetes: results from three cohorts of US adults. Diabetologia 2012; 55: 63-72
21. Rotella F, Mannucci E. Depression as a risk factor for diabetes: a meta-analysis of longitudinal studies. J Clin Psychiatry 2013; 74: 31-37
22. Rubin RR, Ma Y, Peyrot M., et al.; Diabetes Prevention Program Research Group. Antidepressant medicine use and risk of developing diabetes during the diabetes prevention program and diabetes prevention program outcomes study. Diabetes Care 2010; 33: 2549-2551
23. Rosenberg L, Adams-Campbell L, Palmer JR. The Black Women's Health Study: a follow-up study for causes and preventions of illness. J Am Med Womens Assoc 1995; 50: 56-58
24. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977; 1: 385-401
25. Callahan CM, Wolinsky FD The effect of gender and race on the measurement properties of the CES-D in older adults. Med Care 1994; 32: 341-356
26. Nguyen HT, Kitner-Triolo M, Evans M.K., Zonderman AB. Factorial invariance of the CES-D in low socioeconomic status African Americans compared with a nationally representative sample. Psychiatry Res 2004; 126: 177-187
27. Williams CD, Taylor TR, Makambi K, et al CES-D four-factor structure is confirmed, but not invariant, in a large cohort of African American women. Psychiatry Res 2007; 150: 173-180
28. Haringsma R, Engels GI, Beekman A.T., Spinhoven P. The criterion validity of the Center for Epidemiological Studies Depression Scale (CES-D) in a sample of self-referred elders with depressive symptomatology. Int J Geriatr Psychiatry 2004; 19: 558-563
29. Husaini BA, Neff JA, Harrington J.B., Hughes MD, Stone RH. Depression in rural communities: validating the CES-D scale. J Commun Pyschol 1980; 8: 20-27
30. Orr ST, James SA, Blackmore Prince C. Maternal prenatal depressive symptoms and spontaneous preterm births among African-American women in Baltimore, Maryland. Am J Epidemiol 2002; 156: 797-802
31. Phillips GS, Wise LA, Rich-Edwards JW, Stampfer M.J., Rosenberg L. Prepregnancy depressive symptoms and preterm birth in the Black Women's Health Study. Ann Epidemiol 2010; 20: 8-15
32. Carter-Nolan P.L., Adams-Campbell LL, Makambi K., Lewis S, Palmer JR, Rosenberg L. Validation of physical activity instruments: Black Women's Health Study. Ethn Dis 2006; 16: 943-947
33. Block G, Hartman AM, Naughton D. A reduced dietary questionnaire: development and validation. Epidemiology 1990; 1: 58-64
34. Kumanyika SK, Mauger D, Mitchell D.C., Phillips B., Smiciklas-Wright H, Palmer JR. Relative validity of food frequency questionnaire nutrient estimates in the Black Women's Health Study. Ann Epidemiol 2003; 13: 111-118
35. Andersohn F, Schade R, Suissa S., Garbe E. Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus. Am J Psychiatry 2009; 166: 591-598
36. Kivimäki M., Hamer M, Batty G.D., et al. Antidepressant medication use, weight gain, and risk of type 2 diabetes: a population-based study. Diabetes Care 2010; 33: 2611-2616
37. Knol MJ, Geerlings MI, Egberts A.C., Gorter KJ, Grobbee DE, Heerdink ER. No increased incidence of diabetes in antidepressant users. Int Clin Psychopharmacol 2007; 22: 382-386
38. Sambamoorthi U, Ma Y, Findley P.A., Rust G. Antidepressant use, depression, and new-onset diabetes among elderly Medicare beneficiaries. J Diabetes 2013; 5: 327-335
39. Bhattacharjee S, Bhattacharya R, Kelley G.A., Sambamoorthi U. Antidepressant use and newonset diabetes: a systematic review and metaanalysis. Diabetes Metab Res Rev 2013; 29: 273-284
40. Nihalani N, Schwartz TL, Siddiqui U.A., Megna JL. Weight gain, obesity, and psychotropic prescribing. J Obes 2011; 2011: 893629
41. Levkovitz Y, Ben-Shushan G, Hershkovitz A., et al. Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases. Mol Cell Neurosci 2007; 36: 305-312
42. McIntyre RS, Soczynska JK, Konarski J.Z., Kennedy SH. The effect of antidepressants on glucose homeostasis and insulin sensitivity: synthesis and mechanisms. Expert Opin Drug Saf 2006; 5: 157-168
43. Krishnan S, Rosenberg L, Djoussé L, Cupples LA, Palmer JR. Overall and central obesity and risk of type 2 diabetes in U.S. black women. Obesity (Silver Spring) 2007; 15: 1860-1866
44. Krishnan S, Rosenberg L, Palmer JR Physical activity and television watching in relation to risk of type 2 diabetes: the Black Women's Health Study. Am J Epidemiol 2009; 169: 428-434 Disparities